ALYSSA GREENLEAF: Open Payments
NPI 1861896524 · SOUTHINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,502 in 53 payments from 16 companies in 2025. Trend: 2023 $6,119 · 2024 $9,645 · 2025 $9,502
Speaker / faculty: $7,200Food & beverage: $2,126Travel & lodging: $176
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 3 | $7,961 |
| Amgen Inc. | 4 | $293 |
| Abbott Laboratories | 4 | $290 |
| Dexcom, Inc. | 6 | $162 |
| Medtronic, Inc. | 6 | $157 |
| Tandem Diabetes Care, Inc. | 1 | $152 |
| Novo Nordisk Inc | 14 | $138 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Insulet Corporation | 3 | $66 |
| Mannkind Corporation | 1 | $44 |
Products named: CeQur Simplicity, TEPEZZA, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Ozempic, Omnipod.
Industry payments across CT — which companies pay providers there.
